Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for CytRx Corporation (CYTR)

« Back to company index

CYTR Chatter Timeline

Stock Ticker for CYTR

Most Active Tweeters for CYTR

UserTweets
@FlashAlert_me 4
@newsfilterio 4
@InsiderAlerts4U 2
@ontrack9_oktogo 2
@coolcarlos27 1

Recent Tweets for CYTR

letitride1012 @letitride1012
RT @ontrack9_oktogo: $CYTR 's press release in 2016 - that Aldoxorubicin was dosing at that time up to 6500 mg/m2 with NO CARDIO TOXICITY &…
January 25th 2022, 6:01pm
ontrack9_oktogo @ontrack9_oktogo
$CYTR 's press release in 2016 - that Aldoxorubicin was dosing at that time up to 6500 mg/m2 with NO CARDIO TOXICIT… https://t.co/Zhi0pe3f8K
January 24th 2022, 1:01pm
newsfilterio @newsfilterio
Form PRE 14A (other preliminary proxy statements) filed with the SEC $CYTR https://t.co/hp5GKVW59b
January 21st 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$CYTR [15s. delayed] filed form PRE 14A on January 21, 16:05:15 https://t.co/NZDUsXcHnW
January 21st 2022, 9:01pm
ontrack9_oktogo @ontrack9_oktogo
@DrPatSoonShiong Buy them out. $CYTR shareholders want out. You have managed to high roll the patent into your Can… https://t.co/VIRcrjQiG2
January 21st 2022, 1:01pm
newsfilterio @newsfilterio
CytRx to Hold Town Hall for Stockholders on Thursday, January 20th $CYTR https://t.co/mIyOCj30Vt
January 19th 2022, 4:01am
StockNewsBot2 @StockNewsBot2
$CYTR CytRx to Hold Town Hall for Stockholders on Thursday, January 20th https://t.co/y00lk4LFKN
January 18th 2022, 1:01pm
coolcarlos27 @coolcarlos27
$cytr #Bitcoin I’m bullish crypto but in the meantime I invest in these stocks that produce 100-1000% gains fairly… https://t.co/Kv8KQOjll1
January 17th 2022, 12:01am
newsfilterio @newsfilterio
Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $CYTR https://t.co/t9jhD9BEkl
January 12th 2022, 4:01pm
InsiderAlerts4U @InsiderAlerts4U
$CYTR: New Insider Filing on CYTRX CORP's Chief Executive Officer STEPHEN SNOWDY: https://t.co/Fib6u4NMGw
January 12th 2022, 4:01pm
InsiderAlerts4U @InsiderAlerts4U
$CYTR: New Insider Filing on CYTRX CORP's Chief Executive Officer STEPHEN SNOWDY: https://t.co/c5b2ZeD1PR
January 12th 2022, 4:01pm
FlashAlert_me @FlashAlert_me
$CYTR [15s. delayed] filed SEC form 4: Chief Executive Officer Snowdy Stephen: Transacted Derivative Securities on… https://t.co/kq5khjl6Sc
January 12th 2022, 3:01pm
FlashAlert_me @FlashAlert_me
$CYTR [15s. delayed] filed SEC form 3: Chief Executive Officer Snowdy Stephen: https://t.co/LBqWhMthOj
January 12th 2022, 3:01pm
FlashAlert_me @FlashAlert_me
$CYTR [15s. delayed] filed SEC form 4/A: Director Simpson Jennifer K.: Transacted Derivative Securities on 2021-12… https://t.co/TekLjjhs9E
January 12th 2022, 2:01am
newsfilterio @newsfilterio
Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $CYTR https://t.co/lpu0oY30eq
January 12th 2022, 2:01am
dsrgvr @dsrgvr
The reported earnings of $CYTR in recent quarters seem unreasonable. The discretionary accruals are very high. Thes… https://t.co/Gfo2iTZTzz
January 11th 2022, 8:01am
ontrack9_oktogo @ontrack9_oktogo
@DrPatSoonShiong Soon Shiong bombs $CYTR shareholders 2017 catches Aldoxorubicin - delays it, prevents it from goin… https://t.co/HnfvTpJzGP
January 10th 2022, 4:01am
1stOncology @1stOncology
#CytRx to Participate in the #HCWainwrightBioConnect Virtual Conference $CYTR https://t.co/b8AxMSLhyq
January 8th 2022, 7:01am
newsfilterio @newsfilterio
CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference $CYTR https://t.co/FMeMVPWtQI
January 7th 2022, 6:01pm
equity_newswire @equity_newswire
$CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/QwQZ6qgDGF
January 7th 2022, 3:01pm
gcassidy718 @gcassidy718
$CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/oQCcvZSEAs
January 7th 2022, 1:01pm
otcdynamics @otcdynamics
$CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/Su5d6u75GG
January 7th 2022, 1:01pm
FlashAlert_me @FlashAlert_me
$CYTR [15s. delayed]: Issued Press Release on January 07, 08:00:00: CytRx to Participate in the H.C. Wainwright Bio… https://t.co/hLtJ3Luc1m
January 7th 2022, 1:01pm
StockNewsBot2 @StockNewsBot2
$CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/I1p2xSrjtg
January 7th 2022, 1:01pm
bthefirsttoknow @bthefirsttoknow
First out// $CYTR: CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/kZN0L9QGcb
January 7th 2022, 1:01pm
XBRhell @XBRhell
@adamfeuerstein can we get a tweet about $CYTR Steve Kriegsman's $6MM lump sum severance? Over 36% of cash as of 9/… https://t.co/bF8cx850SE
January 5th 2022, 3:01pm
coolcarlos27 @coolcarlos27
$CYTR Told ya it doesn’t pay to ignore my calls $CREG
January 4th 2022, 3:01pm
FlashAlert_me @FlashAlert_me
$CYTR [15s. delayed] filed form 8-K on January 04, 09:09:40 https://t.co/4T5ZK70DBX
January 4th 2022, 2:01pm
pablodesaavedra @pablodesaavedra
Finally good news in CYTRX an incompetent is leaving $cytr #aldoxorubicin #arimoclomol https://t.co/EvuNqZeyaR
January 3rd 2022, 5:01pm
equity_newswire @equity_newswire
$CYTR  CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/yLZrLiCdgv
January 3rd 2022, 3:01pm
gcassidy718 @gcassidy718
$CYTR  CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/f8FCyyzwjA
January 3rd 2022, 1:01pm
ScryingBiotech @ScryingBiotech
$CYTR Allegedly (as there’s no PR yet on the company website) CEO Steven Kriegsman is stepping down effective 1/10/… https://t.co/VuRIV8Tyy2
January 3rd 2022, 1:01pm
otc_watch_news @otc_watch_news
$CYTR #OTCQB CytRx Corp. (CYTR: OTCQB) |  CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive… https://t.co/WIem9Xegj9
January 3rd 2022, 1:01pm
otcdynamics @otcdynamics
$CYTR CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/PTRtndWmz0
January 3rd 2022, 1:01pm
newsfilterio @newsfilterio
CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer $CYTR https://t.co/wZJWjtuMjJ
January 3rd 2022, 1:01pm
FlashAlert_me @FlashAlert_me
$CYTR [15s. delayed]: Issued Press Release on January 03, 08:00:00: CytRx Announces the Appointment of Dr. Stephen… https://t.co/Zf1WekZPy9
January 3rd 2022, 1:01pm
StockNewsBot2 @StockNewsBot2
$CYTR CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/sZr8hQF0WZ
January 3rd 2022, 1:01pm
coolcarlos27 @coolcarlos27
#bitcoin I like this but not as much as the stocks I own $CREG $CYTR watch and learn from the best
January 1st 2022, 6:01am
StckPro @StckPro
$CYTR NEW ARTICLE : ImmunityBio pares gains following aldoxorubicin data in cancer https://t.co/9cZ5pGf4hd Get all… https://t.co/YtP2KH2cK5
December 28th 2021, 5:12pm
PenkeTrading @PenkeTrading
I found you a Death Cross on the daily chart of Cyclops Treasure. $CYTR $CYTR.CC #deathcross #bearish #crypto… https://t.co/yLMQq7R7O6
December 27th 2021, 2:12pm
hephaistos_ai @hephaistos_ai
RT @1stOncology: #CytRx Highlights #ImmunityBios Use of #Aldoxorubicin in Ongoing Clinical Studies for Various Forms of #Cancer $CYTR $IBRX…
December 22nd 2021, 10:12am
hephaistos_ai @hephaistos_ai
RT @1stOncology: #CytRx Highlights #ImmunityBios Use of #Aldoxorubicin in Ongoing Clinical Studies for Various Forms of #Cancer $CYTR https…
December 22nd 2021, 10:12am
1stOncology @1stOncology
#CytRx Highlights #ImmunityBios Use of #Aldoxorubicin in Ongoing Clinical Studies for Various Forms of #Cancer $CYTR https://t.co/m9kkF7Z9nj
December 22nd 2021, 10:12am
sgre2893 @sgre2893
Recent quarterly reports reveal $CYTR may be involved in profit manipulation. Its average discretionary accruals (t… https://t.co/UkvmvJ0YBR
December 22nd 2021, 3:12am
equity_newswire @equity_newswire
$CYTR CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer https://t.co/0sHiP0PEuA
December 21st 2021, 9:12pm
newsfilterio @newsfilterio
CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer $CYTR… https://t.co/aYqZ4CnMKM
December 21st 2021, 7:12pm
gcassidy718 @gcassidy718
$CYTR CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer https://t.co/qyjkhbt0ty
December 21st 2021, 3:12pm
otc_watch_news @otc_watch_news
$CYTR #OTCQB CytRx Corp. (CYTR: OTCQB) | CytRx Highlights ImmunityBio’s Use of Aldoxorubicin in Ongoing Clinical St… https://t.co/nDqJw0hvic
December 21st 2021, 1:12pm
GapUp4 @GapUp4
$CYTR $IBRX CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer
December 21st 2021, 1:12pm
otcdynamics @otcdynamics
$CYTR CytRx Highlights ImmunityBio’s Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer https://t.co/IR7axGSzHq
December 21st 2021, 1:12pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.